Carrato C, Alameda F, Esteve-Codina A, Pineda E, et al. Glioblastoma TCGA mesenchymal and IGS 23 tumors are identifiable by immunohistochemistry and have an immune-phenotype indicating potential benefit from immunotherapy. Clin Cancer Res 2020 Sep 30. pii: 1078-0432.CCR-20-2171.
PMID: 32998960